Supporting Research in Health Disparities, Policy, and Ethics in Alzheimer's Disease and Dementia Research (HPE-ADRD)
Funding to increase understanding and develop strategies to address diversity, equity, and inclusion in Alzheimer's disease and related dementia research. Populations of focus include individuals living in geographies identified as underserved (rural and urban), among others. Geographic coverage: Nationwide -- Alzheimer's Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - November 20, 2023 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
Notice NOT-AG-23-060 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2023 Category: Research Source Type: funding
Healthy Brain Initiative (HBI) Road Map Strategists Program
Funding to increase the capacity of local health departments (LHDs), tribal health organizations, and their community partners to address cognitive health. Geographic coverage: Nationwide -- Alzheimer's Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 24, 2023 Category: American Health Source Type: funding
Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-040 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites U54 Cooperative Agreement applications aiming to establish multi-component Alzheimers Disease and Related Dementias Translational Centers for Microphysiological Systems (MPS) (AD/ADRD MPS Translational Centers). The overarching purpose of this Centers program is to develop 2D and 3D models of AD/ADRD as reproducible and scalable platforms that recapitulate key features of human AD/ADRD pathophysiology to be used as precision medicine research tools to investigate the complex biology of AD/ADRD...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 19, 2023 Category: Research Source Type: funding
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
Funding Opportunity RFA-NS-24-013 from the NIH Guide for Grants and Contracts. This RFA will solicit applications for a pivotal phase 3 clinical trial to determine the efficacy of FDA approved monoclonal antibody therapy compared to placebo in diverse "mixed dementia" populations with a focus on vascular contributions. Mixed dementia refers to dementia cases positive for 1) Alzheimer biomarkers, such as amyloid positron emission tomography and/or low cerebrospinal fluid amyloid beta 42 combined with elevated phosphorylated tau; and 2) evidence of vascular contributions based on imaging (white matter disease and/or subcl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 19, 2023 Category: Research Source Type: funding
Notice of Change to Key Dates Listed in RFA-AG-24-027, "Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)"
Notice NOT-AG-23-056 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2023 Category: Research Source Type: funding
Notice of Change to Key Dates Listed in PAR-23-274, "Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)(UG3/UH3 Clinical Trial Required)"
Notice NOT-AG-23-058 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2023 Category: Research Source Type: funding
Notice of Participation of the National Institute on Aging (NIA) in RFA-NS-24-024, "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)"
Notice NOT-AG-23-049 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2023 Category: Research Source Type: funding
Limited Competition: The Harmonized Cognitive Assessment Protocol (HCAP) Network (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-035 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to continue critical ongoing network and infrastructure support for advancing development in a specific high-priority area of behavioral and social research on Alzheimers disease (AD) and AD-related dementias (ADRD): The Harmonized Cognitive Assessment Protocol (HCAP) International AD/ADRD Research Network. Network/infrastructure-building activities include but are not limited to meetings to develop novel research areas and interact on the development of infrastructure; small-scal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2023 Category: Research Source Type: funding
State Dementia Care Research Center (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-033 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites applications for a State Dementia Care Research Center (henceforth Center) which aims to ultimately improve care for persons living with dementia (PLWD) and their caregivers/care partners by building a research evidence base that can be used to improve dementia care coordination, integration, and care transitions in community settings, as well as inform policymaking. With recognition of the differences in provision, coverage, and access to Alzheimer's disease (AD) and Alzheimer's disease relat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for Funding Opportunity PAR-23-258, "Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)"
Notice NOT-AG-23-051 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2023 Category: Research Source Type: funding
Notice of Correction to Foreign Institution Eligibility for RFA-NS-24-024 "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)"
Notice NOT-NS-24-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2023 Category: Research Source Type: funding
Notice of Correction to Table of Page Limits and change to Receipt Date for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)"
Notice NOT-NS-24-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional)
Funding Opportunity RFA-AG-24-031 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for R01 research projects that aim to advance economic research on Alzheimers disease (AD) and AD-related dementias (ADRD) by examining the development and diffusion of treatment/care innovations, payment and treatment models for care and care access for people living with dementia (PLWD) and their caregivers, and?economic factors influencing disease progression addressing AD/ADRD research implementation milestones?1.P,?13.P,?13.M, and?13.N. These projects will be linked to the Co...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2023 Category: Research Source Type: funding
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)
Funding Opportunity RFA-AG-24-030 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center to advance economic research on Alzheimers disease (AD) and AD-related dementias (ADRD) by supporting a consortium of research projects examining the development and diffusion of treatment/care innovations, payment and treatment models for care, care quality and access for people living with dementia (PLWD) and their caregivers, as well as economic factors influencing disease progression to address NIA AD/ADRD research implementation milestones1.P,13.P...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2023 Category: Research Source Type: funding
